To amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries.
Legislative Progress
Introduced
June 14, 2023
Latest Action
June 16, 2023
Primary Sponsor
Earl L. "Buddy" CarterRepublican(GA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
58pct
2d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · fourth_quarter · Medicare/Medicaid
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues Related to Antipsychotic use in Medicaid (HR 4096); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); EPIC Act (HR 7174); BIOSECURE Act (HR 7085); The Mini Act (HR 5547 / S 476).
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $510,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Medicare/Medicaid
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues Related to Antipsychotic use in Medicaid (HR 4096); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); EPIC Act (HR 7174); BIOSECURE Act (HR 7085).
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Implementation of Medicare Part D changes contained in Inflation Reduction Act: annual cap and smoothing / MP3 Medicare Part B and Part D drug pricing Part D patient protections Medicare quality measures for and staffing of long-term care and skilled nursing facilities Medicare use of CED and QALY FY 2025 appropriations for FDA and HHS HR 4096 - Medicaid coverage of antipsychotic medications Medicare coverage of treatment of Alzheimer's
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · second_quarter · Medicare/Medicaid
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues Related to Antipsychotic use in Medicaid (HR 4096); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); EPIC Act (HR 7174).
Client expense: $450,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Capping Medicare Part D Out of Pocket Costs Smoothing Medicare Part D Out of Pocket Costs Medicare Part B and Part D drug pricing Part D patient protections Medicare quality measures for and staffing of long-term care and skilled nursing facilities Implementation of Inflation Reduction Act Medicare use of CED and QALY FY 2024 and FY 2025 appropriations HR 4096 Medicare coverage of treatment of Alzheimer's
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Medicare/Medicaid
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues Related to Antipsychotic use in Medicaid (HR 4096); Orphan Cures Act (HR 5539 / S. 3131); National Plan to End Parkinson's Act (HR 2365 / S. 1064); Protect Rare Act (HR 6094); EPIC Act (HR 7174).
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Medicare Part B and Part D drug pricing; Part D patient protections; Medicare quality measures for and staffing of long-term care and skilled nursing facilities; Implementation of Inflation Reduction Act; Medicare use of CED and QALY; Flat copay for Part D Medicare drugs; FY 2024 appropriations; HR 4096; Medicare coverage of treatment of Alzheimer's
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Medicare/Medicaid
Implementation of the Inflation Reduction Act of 2022; Six Protected Classes: Issues related to protecting patient access to medicines in Medicare; Nursing Home Quality: Issues related to access to medicines for Parkinson's disease patients; HR 4096 - Issues Related to Antipsychotic use in Medicaid; HR 5539 - Orphan Cures Act; HR 2365 / S. 1064 - National Plan to End Parkinson's Act; HR 6094 - Protect Rare Act.
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Health Issues
Capping Medicare Part D Out of Pocket Costs; Smoothing Medicare Part D Out of Pocket Costs; Medicare Part B and Part D drug pricing; Part D patient protections; Medicare quality measures for long-term care and skilled nursing facilities; Implementation of Inflation Reduction Act; Medicare use of CED and QALY; Flat copay for Part D Medicare drugs; FY 2024 appropriations; HR 4096; Medicare coverage of treatment of Alzheimer's
Client expense: Not reported · Firm income: $60,000
2023 · third_quarter · Medicare/Medicaid
Drug Pricing: Implementation of the Inflation Reduction Act of 2022; Protected Classes: Issues related to protecting patient access to medicines in Medicare; Nursing Home Quality: Issues related to medicines in nursing homes; HR 4096 - Issues Related to Antipsychotic use in Medicaid; HR 5539 - Orphan Cures Act; HR 2365 / S. 1064 - National Plan to End Parkinson's Act.
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Medicare/Medicaid
Drug Pricing: Implementation of the Inflation Reduction Act of 2022; Six Protected Classes: Issues related to protecting patient access to medicines in Medicare; Nursing Home Quality: Issues related to medicines in nursing homes; HR 4096; Issues Related to Antipsychotic use in Medicaid.
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Health Issues
H.Res. 436 - Expressing Support for the Designation of the Week of May 22 through26, 2023, as Educator Mental Health Awareness Week" H.R. 498 - 988 Lifeline Cybersecurity Responsibility Act H.R. 734 - Protection of Women and Girls in Sports Act of 2023 H.R. 824 - Telehealth Benefit Expansion for Workers Act of 2023 H.R. 1114 - Long COVID Recovery Now Act H.R. 1201 - Increasing Behavioral Health Treatment Act H.R. 1202 - REDI Act H.R. 1359 / S. 644 - Modernization of Opioid Treatment Act H.R. 1502 - Comprehensive Opioid Recovery Centers (CORC) Reauthorization Act H.R. 1711 / S. 940 - Rural America Health Corps Act H.R. 1839 - Combating Illicit Xylazine Act H.R. 2389 - Resident Physician Shortage Reduction Act of 2023 H.R. 2400 / S. 1165 - Reentry Act of 2023 H.R. 2412 - Helping Kids Cope Act H.R. 2474 - Strengthening Medicare for Patients and Providers Act H.R. 2713 - I CAN Act H.R. 3073 / S. 1452 - Community Mental Wellness and Resilience Act of 2023 H.R. 3074 / S. 971 - Due Process Continuity of Care Act H.R. 3150 / S. 983 - OPIOIDS Act H.R. 3305 / S. 1606 - Black Maternal Health Momnibus Act H.R. 3548 / S. 1700 Pursuing Equity in Mental Health Act H.R. 3713 / S. 1884 Mental Health Services for Students Act H.R.3570 - Comprehensive Response to Fentanyl-Related Substances and Fentanyl-laced Substances Act H.R.3680 - Stop Mental Health Stigma in Our Communities Act H.R. 3736 - Extending Access to Addiction Treatment Act H.R. 3752 - Parity Enforcement Act of 2023 H.R. 3836 - Medicaid Primary Care Improvement Act H.R. 3838 - Preventing Maternal Deaths Reauthorization Act H.R. 3841 - To amend title III of the Public Health Service Act to reauthorize the program of payments to children's hospitals that operate graduate medical education programs. H.R. 3887 - Childrens Hospital GME Support Reauthorization Act of 2023 H.R. 3892 - Improving Mental Health and Drug Treatment Act H.R. 4007 - HEAL Act H.R. 4053 - Studying Suboxone Act H.R. 4054 - Trauma Support and Mental Health in Schools Reauthorization Act H.R. 4056 - Ensuring Medicaid Continuity for Children in Foster Care Act of 2023 H.R. 4057 - Keeping Kids Safe Act H.R. 4063 - FIND Fentanyl Act of 2023 H.R. 4079 - Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization Act of 2023 H.R. 4080 - Trauma-Informed Care Task Force Reauthorization Act of 2023 H.R. 4088 - CAREER Act H.R. 4089 - Safer Response Act H.R. 4091 - Combatting Substance Use Disorder Act H.R. 4092 - Protecting Moms and Infants Reauthorization Act H.R. 4093 - Remote Opioid Monitoring Act of 2023 H.R. 4095 - Save Children from Trauma Act H.R. 4096 - A bill to amend title XIX of the Social Security Act to expand the application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries H.R. 4097 - Mental Health Improvement Act H.R. 4098 - Communities of Recovery Reauthorization Act H.R. 4099 - RECONNECTS Act of 2023 H.R. 4100 - To amend the Public Health Service Act to reauthorize a monitoring and education program regarding infections associated with illicit drug use and other risk factors H.R. 4101 - Road to Recovery Act H.R. 4106 - To amend the 21st Century Cures Act to expressly authorize the use of certain grants to implement substance use disorder and overdose prevention activities with respect to fentanyl and xylazine test strips H.R. 4189 / S. 2016 - CONNECT for Health Act S. 462 - Mental Health Professionals Workforce Shortage Loan Repayment Act S. 665 - Conrad State 30 and Physician Access Reauthorization Act S. 669 - Increasing Mental Health Options Act of 2023 S. 923 - Better Mental Health Care for Americans Act S.1378 - Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act S. 1426 - RISE from Trauma Act
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $193,806 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE